GRACE

Latest SEC Filings & News for GRACE

2 most recent filings and news items mentioning GRACE. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/GRACE/news?limit=20"

Pull GRACE filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
RegulatoryJun 18, 2026Positive

Grace Therapeutics presents corporate strategy for GTx-104 and GTx-102 programs

Grace Therapeutics released a June 2026 corporate presentation outlining its drug development pipeline and regulatory strategy. The company is pursuing FDA approval for GTx-104 for aneurysmal subarachnoid hemorrhage treatment and advancing GTx-102 for Ataxia Telangiectasia, with

View filing at SEC.gov →
OtherJun 5, 2026Neutral

Grace Therapeutics enters consulting agreement with Carrie D'Andrea effective June 5, 2026

Grace Therapeutics, Inc. executed a consulting agreement with Carrie D'Andrea for professional services with compensation and terms detailed in Exhibit A. The agreement includes standard confidentiality obligations with a 10-year post-termination non-disclosure period.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.